Botanical species · safety record

Bassia scoparia

The EFSA Compendium of Botanicals holds 8 constituent measurements and 1 adverse-effect record for Bassia scoparia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Bassia scoparia (L.) A.J.Scott

8Constituent measurements

1Safety records

4Cited sources

51Licensed products (Canada)

Also recorded as

Kochia scoparia (L.) Schrad.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 51 licensed products naming Bassia scoparia as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Fruit

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Oxalates	Aril	—	4.8 Percent	—	Resolve DOI
Triterpene saponins	Seed	—	16.4 Gram/kilogram	Gaschromatography (GC)	Resolve DOI
Alkaloids	Unspecified	—	—	—	No resolvable identifier
Harman	Aerial part of plants	Solvent extraction	3 Milligram/kilogram	—	No resolvable identifier
Harmine	Aerial part of plants	Solvent extraction	0.5 Milligram/kilogram	—	No resolvable identifier
Nitrates	—	—	—	—	No resolvable identifier
Oxalates	Unspecified	—	—	—	No resolvable identifier
Saponins	Unspecified	—	—	—	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Neurotoxicity	Brain	Unspecified	—	Cattle (as animal)	Short-term toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

DICKIE, CW., JAMES, LF. KOCHIA-SCOPARIA POISONING IN CATTLE. Journal of the american veterinary medical association, 1983, vol. 183, no. 7, p. 765-768.
Coxworth, E. C. M., Salmon, R. E. Kochia seed as a component of the diet of turkey poults. Effects of different methods of saponin removal or inactivation.. Canadian Journal of Animal Science, 1972, vol. 52, no. 4, p. 721-9. DOI
Rahman, M. M., Abdullah, R. B., Khadijah, W. E. Wan. A review of oxalate poisoning in domestic animals: tolerance and performance aspects . Journal of animal physiology and animal nutrition, 2013, vol. 97, no. 4, p. 605-614. DOI
DROSTKARBOWSKA, K., KOWALEWSKI, Z., PHILLIPSON, JD. ISOLATION OF HARMANE AND HARMINE FROM KOCHIA-SCOPARIA. Lloydia-the journal of natural products, 1978, vol. 41, no. 3, p. 289-290.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature